Date: 13-Aug-2019

USFDA issues 6 observations to Natco Pharmas API facility near Hyderabad

NEW DELHI: Natco Pharma on Monday said the US health regulator has made six observations after the completion of inspection of active pharmaceutical ingredient (API) facility in Mekaguda Village, near Hyderabad. The United States Food and Drug Administration (USFDA) conducted inspection at Kothur facility between August 5-9, 2019.